UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Immunoproteasome in cancer and neuropathologies: a new therapeutic target?

Current pharmaceutical design, 2013-02, Vol.19 (4), p.702

2013

Link zum Volltext

Verfügbarkeit prüfen

Evidence of polymorphic CYP2C19 involvement in the human metabolism of N-desmethylclobazam

Therapeutic drug monitoring, 2002-12, Vol.24 (6), p.737-741

2002

Link zum Volltext

Verfügbarkeit prüfen

Lacosamide therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs

Therapeutic drug monitoring, 2013-12, Vol.35 (6), p.849

2013

Link zum Volltext

Verfügbarkeit prüfen

Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs

Therapeutic drug monitoring, 2004-08, Vol.26 (4), p.375

2004

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic interactions between antiepileptic drugs : Clinical considerations

Clinical pharmacokinetics, 1996-12, Vol.31 (6), p.470-493

1996

Link zum Volltext

Verfügbarkeit prüfen

The effect of a clinically practical exercise on levodopa bioavailability and motor response in patients with Parkinson disease

Clinical neuropharmacology, 2010-09, Vol.33 (5), p.254-256

2010

Link zum Volltext

Verfügbarkeit prüfen

The effect of entacapone on levodopa rate of absorption and latency to motor response in patients with Parkinson disease

Clinical neuropharmacology, 2008-09, Vol.31 (5), p.267-271

2008

Link zum Volltext

Verfügbarkeit prüfen

Topiramate therapeutic monitoring in patients with epilepsy: Effect of concomitant antiepileptic drugs

Therapeutic drug monitoring, 2002-06, Vol.24 (3), p.332-337

2002

Link zum Volltext

Verfügbarkeit prüfen

Kinetic-dynamic monitoring of levetiracetam effects in patients with Parkinson disease and levodopa-induced dyskinesias

Clinical neuropharmacology, 2007-03, Vol.30 (2), p.122-124

2007

Link zum Volltext

Verfügbarkeit prüfen

Levodopa therapy monitoring in patients with Parkinson disease: a kinetic-dynamic approach

Therapeutic drug monitoring, 2001-12, Vol.23 (6), p.621-629

2001

Link zum Volltext

Verfügbarkeit prüfen

Influence of meal ingestion time on pharmacokinetics of orally administered levodopa in Parkinsonian patients

Clinical neuropharmacology, 1987-12, Vol.10 (6), p.527-537

1987

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic optimisation in the treatment of Parkinson's disease

Clinical pharmacokinetics, 1996-06, Vol.30 (6), p.463-482

1996

Link zum Volltext

Verfügbarkeit prüfen

Dopamine transporter gene polymorphism, spect imaging, and levodopa response in patients with Parkinson disease

Clinical neuropharmacology, 2004-05, Vol.27 (3), p.111-115

2004

Link zum Volltext

Verfügbarkeit prüfen

Effect of felbamate on clobazam and its metabolite kinetics in patients with epilepsy

Therapeutic drug monitoring, 1999-12, Vol.21 (6), p.604-608

1999

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic optimisation of dopamine receptor agonist therapy for Parkinson's disease

CNS drugs, 2000-12, Vol.14 (6), p.439-455

2000

Link zum Volltext

Verfügbarkeit prüfen

Concentration-effect relationship of levodopa-benserazide dispersible formulation versus standard form in the treatment of complicated motor response fluctuations in parkinson's disease

Clinical neuropharmacology, 1999-11, Vol.22 (6), p.351-355

1999

Link zum Volltext

Verfügbarkeit prüfen

Excessive daytime sleepiness and levodopa in Parkinson's disease: Polygraphic, placebo-controlled monitoring

Clinical neuropharmacology, 2003-05, Vol.26 (3), p.115-118

2003

Link zum Volltext

Verfügbarkeit prüfen

Drug rash with eosinophilia and systemic symptoms secondary to phenobarbitone

Clinical neuropharmacology, 2003-07, Vol.26 (4), p.177-178

2003

Link zum Volltext

Verfügbarkeit prüfen

Relationship between levodopa concentration, dyskinesias, and motor effect in parkinsonian patients : A 3-year follow-up study

Clinical neuropharmacology, 1997-10, Vol.20 (5), p.409-418

1997

Link zum Volltext

Verfügbarkeit prüfen

A within-subject analysis of carbamazepine disposition related to development in children with epilepsy

Therapeutic drug monitoring, 1992-12, Vol.14 (6), p.457-460

1992

Link zum Volltext

Verfügbarkeit prüfen

Determination of total and free plasma carbamazepine concentrations by enzyme multiplied immunoassay: interference with the 10,11-epoxide metabolite

Therapeutic drug monitoring, 1985-01, Vol.7 (1), p.46-50

1985

Link zum Volltext

Verfügbarkeit prüfen

Increased dosage of carbidopa in Parkinsonian patients on low carbidopa-levodopa regimen. Effect on levodopa bioavailability

Clinical neuropharmacology, 1989-02, Vol.12 (1), p.75-81

1989

Link zum Volltext

Verfügbarkeit prüfen

Valproic acid binding to human serum albumin and human plasma: effects of pH variation and buffer composition in equilibrium dialysis

Therapeutic drug monitoring, 1984-01, Vol.6 (1), p.31-33

1984

Link zum Volltext

Verfügbarkeit prüfen

Rapid and Simple GLC Determination of Valproic Acid and Ethosuximide in Plasma of Epileptic Patients

Journal of pharmaceutical sciences, 1982-01, Vol.71 (1), p.110-111

1982

Link zum Volltext

Verfügbarkeit prüfen

On the Interaction Between Phenytoin and Antineoplastic Agents

Therapeutic drug monitoring, 1985-01, Vol.7 (1), p.123

1985

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

ThemaPharmacology & Pharmacy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Humans
(25)
Male
(18)
Biological And Medical Sciences
(17)
Medical Sciences
(17)
Pharmacology. Drug Treatments
(17)
Female
(16)
Neuropharmacology
(13)
Medical Laboratory Technology
(12)
Toxicology
(12)
Anticonvulsants. Antiepileptics. Antiparkinson Agents
(11)
Clinical Neurology
(11)
Neurosciences & Neurology
(11)
Middle Aged
(10)
Parkinson Disease - Drug Therapy
(10)
Aged
(9)
Adult
(8)
Dose-Response Relationship, Drug
(7)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

Journals@Ovid Complete
(26)
Ingenta
(23)
IngentaConnect Journals
(13)
Springer Nature - Complete Springer Journals
(4)
Nexis Uni
(3)
Wiley Online Library Journals Frontfile Complete
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immunoproteasome in cancer and neuropathologies: a new therapeutic target?

Evidence of polymorphic CYP2C19 involvement in the human metabolism of N-desmethylclobazam

Lacosamide therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs

Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs

Pharmacokinetic interactions between antiepileptic drugs : Clinical considerations

The effect of a clinically practical exercise on levodopa bioavailability and motor response in patients with Parkinson disease

The effect of entacapone on levodopa rate of absorption and latency to motor response in patients with Parkinson disease

Topiramate therapeutic monitoring in patients with epilepsy: Effect of concomitant antiepileptic drugs

Kinetic-dynamic monitoring of levetiracetam effects in patients with Parkinson disease and levodopa-induced dyskinesias

Levodopa therapy monitoring in patients with Parkinson disease: a kinetic-dynamic approach

Influence of meal ingestion time on pharmacokinetics of orally administered levodopa in Parkinsonian patients

Pharmacokinetic optimisation in the treatment of Parkinson's disease

Dopamine transporter gene polymorphism, spect imaging, and levodopa response in patients with Parkinson disease

Effect of felbamate on clobazam and its metabolite kinetics in patients with epilepsy

Pharmacokinetic optimisation of dopamine receptor agonist therapy for Parkinson's disease

Concentration-effect relationship of levodopa-benserazide dispersible formulation versus standard form in the treatment of complicated motor response fluctuations in parkinson's disease

Excessive daytime sleepiness and levodopa in Parkinson's disease: Polygraphic, placebo-controlled monitoring

Drug rash with eosinophilia and systemic symptoms secondary to phenobarbitone

Relationship between levodopa concentration, dyskinesias, and motor effect in parkinsonian patients : A 3-year follow-up study

A within-subject analysis of carbamazepine disposition related to development in children with epilepsy

Determination of total and free plasma carbamazepine concentrations by enzyme multiplied immunoassay: interference with the 10,11-epoxide metabolite

Increased dosage of carbidopa in Parkinsonian patients on low carbidopa-levodopa regimen. Effect on levodopa bioavailability

Valproic acid binding to human serum albumin and human plasma: effects of pH variation and buffer composition in equilibrium dialysis

Rapid and Simple GLC Determination of Valproic Acid and Ethosuximide in Plasma of Epileptic Patients

On the Interaction Between Phenytoin and Antineoplastic Agents

Aktive Filter

Suchergebnisse filtern